DW Healthcare Partners has made an investment in Med-Pharmex, a provider of animal health products.
Med-Pharmex offers pharmaceutical research, formulation, and manufacturing in the animal health industry. Med-Pharmex’s veterinary pharmaceuticals include products for companion animals, such as dogs, cats, and horses, and food-producing animals, such as cattle, swine and poultry. The company operates three manufacturing facilities and is headquartered in Pomona, CA (www.med-pharmex.com).
“We are very pleased to have this opportunity to partner with Gerald Macedo and his talented team at Med-Pharmex. The company is uniquely positioned within the animal health market. It will provide us with a stable platform that can be further leveraged as new products are added to the portfolio, via internal research and development, product acquisitions, and strategic manufacturing partnerships,” said Andrew Carragher, Co-founder and Managing Director of DW Healthcare Partners.
DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $500 million in committed capital and invests in profitable healthcare companies with proven management teams. DW Healthcare Partners is currently seeking investment opportunities for its third fund which has $265 million of committed capital. The firm is based in Park City, UT (www.dwhp.com).
“Our partnership with DW Healthcare Partners will allow us to take advantage of some exciting growth opportunities,” said Gerald Macedo, CEO of Med-Pharmex. “The financial stability and flexibility now available to us through this investment in our company will enable us to move forward with our acquisition and product development plans.”
© 2013 PEPD • Private Equity’s Leading News Magazine • 5-2-13